DH
Definitive Healthcare Corp.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.40
P/S
0.48
EV/EBITDA
-0.88
DCF Value
$-7.95
FCF Yield
40.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.9%
Operating Margin
-8.5%
Net Margin
-57.5%
ROE
-46.6%
ROA
-18.9%
ROIC
-3.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $61.5M | $-9.3M | $-0.09 |
| FY 2025 | $241.5M | $-138.9M | $-1.30 |
| Q3 2025 | $60.0M | $-14.8M | $-0.14 |
| Q2 2025 | $60.8M | $-7.6M | $-0.07 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.60
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.